These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26342441)

  • 21. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
    Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
    Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
    Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
    Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
    Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of cytokine expression in the pre-implanted donor lung on the development of chronic lung allograft dysfunction subtypes.
    Saito T; Takahashi H; Kaneda H; Binnie M; Azad S; Sato M; Waddell TK; Cypel M; Liu M; Keshavjee S
    Am J Transplant; 2013 Dec; 13(12):3192-201. PubMed ID: 24164971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of 18F-FDG PET/CT in Restrictive Allograft Syndrome After Lung Transplantation.
    Verleden SE; Gheysens O; Goffin KE; Vanaudenaerde BM; Verbeken EK; Weynand B; Van Raemdonck DE; Verleden GM; Vos R
    Transplantation; 2019 Apr; 103(4):823-831. PubMed ID: 30086092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure.
    Verleden SE; Vasilescu DM; McDonough JE; Ruttens D; Vos R; Vandermeulen E; Bellon H; Geenens R; Verbeken EK; Verschakelen J; Van Raemdonck DE; Wuyts WA; Sokolow Y; Knoop C; Cooper JD; Hogg JC; Verleden GM; Vanaudenaerde BM
    Eur Respir J; 2015 Nov; 46(5):1430-9. PubMed ID: 26113688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative CT Correlates with Local Inflammation in Lung of Patients with Subtypes of Chronic Lung Allograft Dysfunction.
    Ram S; Verleden SE; Bell AJ; Hoff BA; Labaki WW; Murray S; Vanaudenaerde BM; Vos R; Verleden GM; Kazerooni EA; Galbán S; Hatt CR; Han MK; Lama VN; Galbán CJ
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and computed tomographic evolution and survival of restrictive allograft syndrome after lung transplantation.
    Verleden SE; de Jong PA; Ruttens D; Vandermeulen E; van Raemdonck DE; Verschakelen J; Vanaudenaerde BM; Verleden GM; Vos R
    J Heart Lung Transplant; 2014 Mar; 33(3):270-7. PubMed ID: 24461432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multivariate modeling using quantitative CT metrics may improve accuracy of diagnosis of bronchiolitis obliterans syndrome after lung transplantation.
    Barbosa EM; Simpson S; Lee JC; Tustison N; Gee J; Shou H
    Comput Biol Med; 2017 Oct; 89():275-281. PubMed ID: 28850899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold?
    Snell GI; Paraskeva M; Westall GP
    Paediatr Drugs; 2013 Aug; 15(4):281-9. PubMed ID: 23605986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
    Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
    Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lobe-wise assessment of lung volume and density distribution in lung transplant patients and value for early detection of bronchiolitis obliterans syndrome.
    Dettmer S; Suhling H; Klingenberg I; Otten O; Kaireit T; Fuge J; Kuhnigk JM; Gottlieb J; Haverich A; Welte T; Wacker F; Vogel-Claussen J; Shin HO
    Eur J Radiol; 2018 Sep; 106():137-144. PubMed ID: 30150035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey.
    Kapila A; Baz MA; Valentine VG; Bhorade SM;
    J Heart Lung Transplant; 2015 Jan; 34(1):65-74. PubMed ID: 25447585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
    Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis.
    Vanstapel A; Goldschmeding R; Broekhuizen R; Nguyen T; Sacreas A; Kaes J; Heigl T; Verleden SE; De Zutter A; Verleden G; Weynand B; Verbeken E; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Schoemans HM; Vanaudenaerde BM; Vos R
    Front Immunol; 2021; 12():661761. PubMed ID: 34122421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restrictive allograft syndrome after lung transplantation: new radiological insights.
    Dubbeldam A; Barthels C; Coolen J; Verschakelen JA; Verleden SE; Vos R; Verleden GM; De Wever W
    Eur Radiol; 2017 Jul; 27(7):2810-2817. PubMed ID: 27878373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.